Publication: Choice of first line systemic treatment in pancreatic cancer among national experts
Choice of first line systemic treatment in pancreatic cancer among national experts
Date
Date
Date
Citations
Glatzer, M., Horber, D., Montemurro, M., Winterhalder, R., Inauen, R., Berger, M. D., Pestalozzi, B., Pederiva, S., Pless, M., & Putora, P. M. (2020). Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology, 20(4), 686–690. https://doi.org/10.1016/j.pan.2020.03.012
Abstract
Abstract
Abstract
BACKGROUND
Treatment options for patients with metastatic pancreatic cancer depend on various factors, including performance status, tumor burden and patient preferences. Metastatic pancreatic cancer is incurable and many systemic treatment options have been investigated over the past decades. This analysis of patterns of practice was performed to identify decision criteria and their impact on the choice of first-line management of metastatic pancreatic cancer.
MATERIALS AND METHODS
Members of the Swiss Group for Clinical Cancer Re
Metrics
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Publisher DOI
Metrics
Views
Citations
Glatzer, M., Horber, D., Montemurro, M., Winterhalder, R., Inauen, R., Berger, M. D., Pestalozzi, B., Pederiva, S., Pless, M., & Putora, P. M. (2020). Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology, 20(4), 686–690. https://doi.org/10.1016/j.pan.2020.03.012